Trial Information
Alzheimers? Be a Part of Research.
This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer’s disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline of Alzheimer’s disease as compared with placebo (a substance that looks like the study drug, but has no medicine).
Qualified Participants Must: Be diagnosed with a mild to moderate form of Alzheimer’s disease; Have a reliable caregiver who is in frequent contact with you; Have good veins
Qualified Participants Will Receive: $50 per completed study visit.
Apex Research Institute
999 N. Tustin Ave., #120
Santa Ana, CA 92705
Phone: 714-542-3008